1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors
| Autor: | Marron, T.U., Misleh, J.G., C. chen, Wainberg, Z.A., Powderly, J., Boccia, R., Gordon, M., Segar, J., Csiki, I., Schanzer, J.M., O'Toole, L., Huang, N., Seppa, J., Glenn, J., Klumpp, K., Spira, A.I. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S623-S624 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|